Skip to main content
SpringerLink
Log in

Virale Erkrankungen durch DNA-Viren

  • Chapter
Die Infektiologie

Zusammenfassung

Viren sind subzellulär strukturierte Infektionserreger. Sie bestehen aus Erbgut [aus einer Ribo- oder Desoxyribonukleinsäure (RNA oder DNA)] und aus einer Außenhülle. Bei der umgebenden Hülle handelt es sich um eine Proteinkapsel mit oder ohne zusätzliches »Tegument« und Außenmembran, dem sog. Envelope. Einige Viren enthalten Enzyme für die initiale RNA- bzw. DNA-Transkription. Enzymatisch aktive Moleküle finden sich auch auf dem Envelope bestimmter Viren. Sie befähigen die Viren, sich an die Infektionszielzellen anzuheften oder Membranstrukturen aus ihnen freizusetzen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 449.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Doerr HW (1999) Alte und neue Aspekte in der Pathogenese von Viruskrankheiten. In: Wacha H (Hrsg) Infektiologie heute — Zeit zum Umdenken. Zuckerschwerdt, München, S 77 ff.

    Google Scholar 

  2. Bugert JJ, Darai G (1997) Recent advances in molluscum contagiosum virus research. Arch Virol (Suppl) 13:35–47

    CAS  Google Scholar 

  3. Bugert JJ, Darai G (2000) In: Becker Y, Darai G (eds) Virus genes, special issue: Molecular evolution of viruses — past and present, part 3: Virus genes coding for proteins that affect the host immune system and viral homologues of cellular genes. Virus Genes 21:111–33

    Google Scholar 

  4. Camac LNB (ed) (1959) Classics of medicine and surgery. Dover, New York, pp 213–240

    Google Scholar 

  5. Cohen J (1997) The rise and fall of projet SIDA. Science 277:312–313

    PubMed  CAS  Google Scholar 

  6. De Clercq, E (1997) Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections. Intervirology 40:295–303

    PubMed  Google Scholar 

  7. Douglass NJ, Richardson M, Dumbell KR (1994) Evidence for recent genetic variation in monkeypox viruses. J Gen Virol 75(Pt 6):1303–1309

    PubMed  CAS  Google Scholar 

  8. Esposito JJ, Knight JC (1984) Nucleotide sequence of the thymidine kinase gene region of monkeypox and variola viruses. Virology 135:561–567

    PubMed  CAS  Google Scholar 

  9. Fenner F (1996) The poxviruses. In: Fields N et al. (eds) Virology, 3rd edn. Raven, New York, vol 2, pp 2673–2702

    Google Scholar 

  10. Herrlich A (1967) Die Pocken, 2. Aufl. Thieme, Stuttgart

    Google Scholar 

  11. Hertig C, Coupar BE, Gould AR, Boyle DB (1997) Field and vaccine strains of fowlpox virus carry integrated sequences from the avian retrovirus, reticuloendotheliosis virus. Virology 235:367–376

    PubMed  CAS  Google Scholar 

  12. Mahnel H, Mayr A (1994) Experiences with immunization against orthopox viruses of humans and animals using vaccine strain MVA. Berl Münch Tierärztl Wochenschr 107:253–256.

    PubMed  CAS  Google Scholar 

  13. Mercer A, Fleming S, Robinson A, Nettleton P, Reid H (1997) Molecular genetic analyses of parapoxviruses pathogenic for humans. Arch Virol (Suppl 13): 25–34

    CAS  Google Scholar 

  14. Moss B (1996) Poxviruses. In Fields BN, Knipe DM, Howley PM et al. (eds) Fields virology. Lippincott-Raven, Philadelphia New York, pp 2637–2671

    Google Scholar 

  15. Mutombo M, Arita I, Jezek Z (1983) Human monkeypox transmitted by a chimpanzee in a tropical rain-forest area of Zaire. Lancet 1:735–737

    PubMed  CAS  Google Scholar 

  16. Neubauer H, Reischl U, Ropp S et al. (1998) Specific detection of monkeypox virus by polymerase chain reaction. J Virol Methods 74:201–207

    PubMed  CAS  Google Scholar 

  17. Baker DA (1992) Herpes simplex virus infections. Curr Opin Obstet Gynecol 4:676–681

    PubMed  CAS  Google Scholar 

  18. Chenot JF, Rabenau HF, Doerr HW (1999) Virologie, Epidemiologie und Diagnose des Herpes genitalis. Dtsch Med Wochenschr 124/12:58–162

    Google Scholar 

  19. Desselberger U (1998) Herpes simplex virus infection in pregnancy: Diagnosis and significance. Intervirology 41:185–190

    PubMed  CAS  Google Scholar 

  20. Jacobs RF (1998) Neonatal herpes simplex virus infections. Semin Perinatol 22:64–71

    PubMed  CAS  Google Scholar 

  21. Pereira FA (1996) Herpes simplex: evolving concepts. J Am Acad Dermatol 35:503–520

    PubMed  CAS  Google Scholar 

  22. Wutzier P (1997) Antiviral therapy of herpes simplex and varicella-zoster virus infections. Intervirology 40:343–356

    Google Scholar 

  23. Wutzler P, Doerr HW, Färber I, Eichhorn U et al. (2000) Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol 61:201–207

    PubMed  CAS  Google Scholar 

  24. Sauerbrei A, Eichhorn U, Hottenrott G, Wutzler P (2000) Virological diagnosis of herpes simplex encephalitis. J Clin Virol 17:31–36

    PubMed  CAS  Google Scholar 

  25. Subak-Sharpe JH, Dargan DJ (1998) HSV molecular biology: general aspects of herpes simplex virus molecular biology. Virus Genes 16:239–51

    PubMed  CAS  Google Scholar 

  26. Buxbaum S, Doerr HW, Allwinn R (2001) Untersuchungen zur Immunitätslage der impfpräventablen Kinderkrankheiten Röteln, Masern, Mumps und Windpocken. Dtsch Med Wschr 126:1289–1293

    PubMed  CAS  Google Scholar 

  27. Cohen Jl, Straus SE (1996) Varicella-zoster virus and its replication. In: Fields, BN et al. (eds) Virology. Lippincott-Raven, Philadelphia, pp 2547–2586

    Google Scholar 

  28. Doerr HW, Rabenau H (1996) Dermatotrope Herpesviren: Infektionsbiologie, Epidemiologie und Diagnostik. Chemother J 5:1–11

    Google Scholar 

  29. Gershon AA, LaRussa PS (1998) Varicella vaccine. Pediatr Infect Dis J 17:248–249

    PubMed  CAS  Google Scholar 

  30. Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342:635–645

    PubMed  CAS  Google Scholar 

  31. Junker AK, Angus E, Thomas EE (1991) Recurrent varicella-zoster virus infections in apperently immunocompetent children. Pediatr Infect Dis J 10:569–775

    PubMed  CAS  Google Scholar 

  32. Meister W et al. (1998) Demography, symptomatology and course of disease in ambulatory zoster patients. Intervirology 41:272–277

    PubMed  CAS  Google Scholar 

  33. Recommendations of the Advisory Committee on Immunization Practices (ACIP) (1996). Varicella prevention. Morb Mortal Weekly Rep 45 (RR-11-37

    Google Scholar 

  34. Sauerbrei A(1998) Varicella-zoster virus infections in pregnancy. Intervirology 41:191–196

    Google Scholar 

  35. Scholz H (2000) Varizellen-Zoster. In: Deutsche Gesellschaft für pädiatrische Infektiologie Handbuch. Infektionen bei Kindern und Jugendlichen, 3. Aufl. Futuramed, München, S 635–641

    Google Scholar 

  36. Suga S, Yoshikawa T, Ozaki T, Asano Y (1993) Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Arch Dis Childh 69:639–643

    PubMed  CAS  Google Scholar 

  37. Wolff MH, Schünemann S, Schmidt A (eds) (1999) Varicella-zoster virus: molecular biology, pathogenesis and clinical aspects. Karger, Basel (Contributions to Microbiology, vol 3)

    Google Scholar 

  38. Aitken C, Barrett-Muir W, Millar C et al. (1999) Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation. J Clin Microbiol 37:2804–2807

    PubMed  CAS  Google Scholar 

  39. Berger A, Preiser W (2002) Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV. J Antimicrob Chemother 49/5:713–721

    PubMed  CAS  Google Scholar 

  40. Braun W, Weber B, Moell U, Hamann A, Doerr HW (1993). Immunoglobulin A and M patterns to human cytomegalovirus during recurrent infection in patients with AIDS using a modified western blot. J Virol Methods 43:65–76

    PubMed  CAS  Google Scholar 

  41. Bresnahan WA, Shenk T (2000) A subset of viral transcripts packaged within human cytomegalovirus particles. Science 288:2373–2376

    PubMed  CAS  Google Scholar 

  42. Cinatl J Jr, Cinatl J, Vogel J-U et al. (1998) Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res 58:367–372

    PubMed  CAS  Google Scholar 

  43. Cinatl J Jr, Kotchetkov R, Scholz M et al. (1999) Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. Am J Pathol 155:285–292

    PubMed  CAS  Google Scholar 

  44. Cinatl J Jr, Blaheta R, Bittoova M, Scholz M, Margraf S, Vogel JU (2000) Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced upregulation of Fas ligand independent of neutrophil apoptosis. J Immunol 165(8): 4405–4413

    PubMed  CAS  Google Scholar 

  45. Cinatl J Jr, Margraf S, Vogel JU, Scholz M, Cinatl J, Doerr HW (2001) Human cytomegalovirus circumvents NF-kappa B dependence in retinal pigment epithelial cells. J Immunol 167(4): 1900–1908

    PubMed  CAS  Google Scholar 

  46. Dhanak D, Burton G, Christmann LT et al. (2000) Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease. Bioorg Med Chem Lett 10:2279–2282

    PubMed  CAS  Google Scholar 

  47. Doerr HW (1987) Cytomegalovirus infection in pregnancy. J Virol Methods 17:127–132

    PubMed  CAS  Google Scholar 

  48. Doerr HW, Braun R Munk K (1985) Human Cytomegalovirus Infection: Recent Developments in Diagnosis and Epidemiology. Klin Wochenschr 63:241–251

    PubMed  CAS  Google Scholar 

  49. Doerr HW, Kunzler A, Schmitz H (1979) Cytomegalovirus strain differentiation by DNA restriction analysis. Oncology 36:245–247

    PubMed  CAS  Google Scholar 

  50. Einsele H, Hebart H, Kauffmann-Schneider C et al. (2000) Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant 25:757–763

    PubMed  CAS  Google Scholar 

  51. Emery VC, Hassan-Walker AF, Burroughs AK, Griffiths PD (2002) Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and-experienced immunocompromised hosts. J Infect Dis 185/12:1723–1728

    PubMed  Google Scholar 

  52. Emery VC, Cope AV, Sabin CA et al. (2000) Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation. J Infect Dis 182:1610–1615

    PubMed  CAS  Google Scholar 

  53. Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G (2001) Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 357:513–518

    PubMed  CAS  Google Scholar 

  54. Humar A, Gregson D, Caliendo AM et al. (1999) Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 68:1305–1311

    PubMed  CAS  Google Scholar 

  55. Jean F, Thomas L, Molloy SS, Liu G, Jarvis MA, Nelson JA, Thomas G (2000) A protein-based therapeutic for human cytomegalovirus infection. Proc Natl Acad Sci USA 97:2864–2869

    PubMed  CAS  Google Scholar 

  56. Kaariainen L, Klemola E, Paloheimo J (1966) Rise of cytomegalovirus antibodies in an infectious-mononucleosis-like syndrome after transfusion. BMJ 2:1270–1272

    Google Scholar 

  57. Krech U, Jung M, Jung F (1971) CMV Infections of man. Karger, Basel

    Google Scholar 

  58. Landini MP, Michelson S (1988) Human cytomegalovirus proteins. Prog Med Virol 35:152–185

    PubMed  CAS  Google Scholar 

  59. Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP (2000) Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 137:90–95

    PubMed  CAS  Google Scholar 

  60. Ljungmann P, Plothin SA (1995): Workshop of CMV disease: definitions, clinical severity scores, and new synchrones. Scand J Infect Dis Suppl 99:87–89

    Google Scholar 

  61. Meyer-König U, Haberland M, von Laer D, Haller O, Hufert FT (1998) Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis 177/5:1162–1169

    PubMed  Google Scholar 

  62. Mocarski ES Jr, Courcelle CT (2001) Cytomegaloviruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, vol 2, chap 76. 4th edn. Lippincott — Williams&Wilkins, Philadelphia

    Google Scholar 

  63. Nichols WG, Boeckh M (2000) Recent advances in the therapy and prevention of CMV infections. J Clin Virol 16:25–40

    PubMed  CAS  Google Scholar 

  64. Nigro G, Schiavetti A, Booth JC et al. (1995) Cytomegalovirus-associated stage 4S neuroblastoma relapsed stage 4. Med Pediatr Oncol 24:200–203

    PubMed  CAS  Google Scholar 

  65. Pass RF, Stagno S, Myers GJ, Alford CA (1980) Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics 66:758–762

    PubMed  CAS  Google Scholar 

  66. Preiser W, Bräuninger S, Schwerdtfeger R et al. (2001) Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants. J Clin Viro. 20:59–70

    CAS  Google Scholar 

  67. Prösch S, Volk HD, Reinke P, Pioch K, Docke WD, Krüger DH (1998). Human cytomegalovirus infection in transplant recipients: Role of TNF-alpha for reactivation and replication of human cytomegalovirus. In: Scholz M, Rabenau H, Doerr HW, Cinatl J Jr (eds) CMV-related immunopathology. Karger, Basel (Monographs in virology, pp 29–41)

    Google Scholar 

  68. Radsak K, Brucher KH, Britt W, Shiou H, Schneider D, Kollert A (1990) Nuclear compartimentation of glycoprotein B of human cytomegalovirus. Virology 177:515–522

    PubMed  CAS  Google Scholar 

  69. Reddehase MJ, Mutter W, Münch K, Bührin H-J, Koszinowski UH (1987) CD8-positive T lymphocytes specific for murine cytomegalovirus immediate early antigens mediate protective immunity. J Virol 61:3102–3108

    PubMed  CAS  Google Scholar 

  70. Robinson MR, Ross ML, Whitcup SM (1999). Ocular manifestations of HIV infection. Curr Opin Ophthalmol 10:431–437

    PubMed  CAS  Google Scholar 

  71. Rosenthal LJ, Choudhury S (1993) Potential oncogenicity of human cytomegalovirus. In: Becker Y, Darai G, Huang ES (eds) Molecular aspects of human cytomegalovirus diseases. Berlin, Springer Heidelberg New York Tokio (Frontiers of virology, vol 2, pp 412–436)

    Google Scholar 

  72. Schacherer C, Braun W, Doerr HW (1988) Detection of cytomegalovirus in bronchial lavage and urine using a monoclonal antibody to an HCMV early nuclear protein. Infection 16:288–292

    PubMed  CAS  Google Scholar 

  73. Scholz M, Cinatl J Jr, Doerr HW (1997). Prophylaxis of cytomegalovirus disease in high-risk patients. Infection 25:269–273

    PubMed  CAS  Google Scholar 

  74. Scholz M, Vogel J-U, Blaheta RA, Doerr HW, Cinatl J Jr (1998) Cytomegalovirus, oxidative stress and inflammation as interdependent pathomechanisms: need for novel therapeutic strategies? In: Scholz M, Rabenau HF, Doerr HW, Cinatl J Jr (eds) CMV-related immunopathology. Karger, Basel

    Google Scholar 

  75. Scholz M, Doerr HW, Cinatl J Jr (2001) Inhibition of cytomegalovirus immediate early gene expression: a therapeutic option? Antiviral Res 49(3): 129–145

    PubMed  CAS  Google Scholar 

  76. Sia IG, Wilson JA, Groettum CM, Espy MJ, Smith TF, Paya CV (2000) Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J Infect Dis 181:717–720

    PubMed  CAS  Google Scholar 

  77. Singh N (2001) Preemptive Therapy Versus Universal Prophylaxis with Ganciclovir for Cytomegalovirus in Solid Organ Transplant Recipients. Clin Infect Dis 32:742–751

    PubMed  CAS  Google Scholar 

  78. Sinzger C, Kahl M, Laib K, Klingel K, Rieger P, Plachter B, Jahn G (2000) Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J Gen Virol 81:3021–3035

    PubMed  CAS  Google Scholar 

  79. Stone SF, Price P, Tay-Kearney ML, French MA (2002) Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment. J Infect Dis 185(12): 1813–1817

    PubMed  CAS  Google Scholar 

  80. The TH, Harmsen MC, van der Bij W, van den Berg AP, van Son WJ (1998) Relationship between monitoring the viral load in blood, human cytomegalovirus pathophysiology and management strategies of patients after transplantation. In: Scholz M, Rabenau H, Doerr HW, Cinatl J Jr (eds) CMV-related immunopathology. Karger, Basel, Monographs in Virology. 262–279

    Google Scholar 

  81. Vogel J-U, Scholz M, Cinatl J Jr (1997) Treatment of CMV diseases. Intervirology 40, 357–367

    PubMed  CAS  Google Scholar 

  82. Walter EA, Greenberg PD, Gilbert MJ et al. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones of the donor. N Engl J Med 333:1038–1044

    PubMed  CAS  Google Scholar 

  83. Weber B, Doerr HW (1994) Diagnosis and epidemiology of transfusion-associated human cytomegalovirus infection: recent developments. Infusionsther.Transfusionsmed 21(Suppl 1): 32–39

    PubMed  Google Scholar 

  84. Weber B, Rabenau H, Berger A et al. (1995) Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups. Zentralbl Bakteriol 282/1:102–112

    PubMed  CAS  Google Scholar 

  85. Weber B, Braun W, Cinatl J Jr, Doerr HW (1993a) Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens. Clin Invest 71:270–276

    CAS  Google Scholar 

  86. Weber B, Hamann A, Ritt B, Rabenau H, Doerr HW (1992) Comparison of shell vial culture and serology for the diagnosis of human cytomegalovirus infection in neonates and immunocompromised subjects. Clin Invest 70:503–507

    CAS  Google Scholar 

  87. Weber B, Klinghardt U, Lux A, Braun W, Rabenau H, Doerr HW (1993b) Detection of neutralizing antibodies against human cytomegalovirus: influence of strain variation. J Med Virol 40:28–34

    PubMed  CAS  Google Scholar 

  88. Kieff E (1995) Epstein-Barr Virus and its replication. In: Fields BN, Knipe DM Howley PM (eds) Fields virology, 3rd edn. Lippincott-Raven, Philadelphia, pp 2343–2396

    Google Scholar 

  89. Rickinson AB, Kieff E (1995) Epstein-Barr Virus. In: Fields BN, Knipe DM Howley PM (eds) Fields virology, 3rd edn. Lippincott-Raven, Philadelphia, pp 2397–2446

    Google Scholar 

  90. Schooley RT (1995) Epstein-Barr Virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R (ed) Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 4th edn. Churchill Livingstone, Philadelphia, pp 1364–1377

    Google Scholar 

  91. Hall CB, Caserta MT(1999) Exanthema subitum (roseola infantum). Herpes 6:64–67

    Google Scholar 

  92. Stefan A, Menotti L, Capadelli-Fiume G (1999) The biology and natural history of two emerging pathogens: human herpesvirus 6 and 7. Herpes 6:78–81

    Google Scholar 

  93. Chan PKS, NG H-K, Cheung JLK, Cheng AF (2000) Survey for the presence and distribution of human herpesvirus 8 in healthy brain. J Clin Microbiol 38:2772–2773

    PubMed  CAS  Google Scholar 

  94. Levy JA (1997) Three new human herpesviruses (HHV-6, 7 and 8). Lancet 349:558–562

    PubMed  CAS  Google Scholar 

  95. Mendez JC, Paya CV (2000) Kaposi’s sarcoma and transplantation. Herpes 7:18–23

    PubMed  Google Scholar 

  96. Whitley RJ (1996) Cercopithecine herpes virus 1 (B Virus). In: Fields virology, 3rd edn. Lippincott-Ravens, Philadelphia, pp 2623–2635

    Google Scholar 

  97. Adrian T, Wigand R, Richter J (1987) Gastroenteritis in infants, associated with a genome type of adenovirus 31 and with combined rotavirus and adenovirus 31 infection. Eur J Pediatr 16:38–40

    Google Scholar 

  98. Allard A, Girones R, Juto P, Wadell G (1990) Polymerase chain reaction for detection of adenoviruses in stool specimens. J Clin Microbiol 28:2659–2667

    PubMed  CAS  Google Scholar 

  99. Bajanowski T, Wiegand P, Cecchi R et al. (1996) Detection and significance of adenoviruses in cases of sudden infant death. Virchows Arch 428:113–118

    PubMed  CAS  Google Scholar 

  100. Berichtssystem zur Erfassung positiver (epidemiologisch auffälliger) Virusbefunde. DW/RKI, Jahresbericht 1999

    Google Scholar 

  101. Bennett FM, Law BB, Hamilton W, McDonald A (1957) Adenovirus eye infections in Aberdeen. Lancet II: 670–673

    Google Scholar 

  102. Brandt CD, Kim HW, Rodriguez WJ et al. (1985) Adenovirus and pediatric gastroenteritis. J Infect Dis 151:437–443

    PubMed  CAS  Google Scholar 

  103. De Jong JC, Wermenbol AG, Verweij-Uijterwaal MW (1996) Adenoviruses from Aids patients, including candidate serotypes 50 and 51 of subgenus B1 and D, respectively. Xth International Congress of Virology 1996, PW48-4, p 231

    Google Scholar 

  104. Fox JP, Haall CE, Cooney MK (1977) The Seattle virus watch. VII. Observations of adenovirus infections. Am J Epidemiol 105:362–386

    PubMed  CAS  Google Scholar 

  105. Guyer B, O’Day DM, Hierholzer JC, Schaffner W (1975) Epidemic keratoconjunctivitis: a community outbreak of mixed adenovirus type 8 and 19 infection. J Infect Dis 132:142–150

    PubMed  CAS  Google Scholar 

  106. Hierholzer JC, Adrian T, Anderson LJ, Wigand R, Gold JWM (1988) Analysis of antigenically intermediate strains of subgenus B and D adenoviruses from AIDS patients. Arch Virol 103:99–115

    PubMed  CAS  Google Scholar 

  107. Horwitz MS (1990) Adenoviridae and their replication. In: Fields BN, Knipe DM, Chanock RM et al. (eds) Virology. Raven, New York, pp 1679–1721

    Google Scholar 

  108. Kidd AH, Jönsson M, Garwicz D et al. (1996) Rapid Subgenus Identification of Human Adenovirus Isolates by a General PCR. J Clin Microbiol 34:622–627

    PubMed  CAS  Google Scholar 

  109. Pring-Åkerblom P, Adrian T (1994) Type-and group-specific polymerase chain reaction for adenovirus detection. Res Virol 145:25–35

    PubMed  Google Scholar 

  110. Pring-Âkerblom P, Adrian T, Köstler T (1997) Polymerase chain reaction based detection and typing of human adenoviruses in clinical samples. Res Virol 148:225–231

    PubMed  Google Scholar 

  111. Pring-Åkerblom P, Trijssenaar FE, Adrian T, Hoyer H (1999) Multiplex polymerase chain reaction for subgenus-specific detection of human adenoviruses in clinical samples. J Med Virol 58:87–92

    PubMed  Google Scholar 

  112. Rowe WP, Huebner RJ, Gillmore LK, Parrot RH, Ward TG (1953) Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 84:570–573

    PubMed  CAS  Google Scholar 

  113. Schmitz H, Wigand R, Heinrich W (1983) Worldwide epidemiology of human adenovirus infections. Am J Epidemiol 117:455–466

    PubMed  CAS  Google Scholar 

  114. Wadell G (1990) Adenoviruses. In: Zuckerman AJ, Banatvala JE, Pattison, JR (eds) Principles and practice of clinical virology. Wiley, Chichester, pp 267–287

    Google Scholar 

  115. De Villiers E-M (1997) Papillomavirus and HPV typing. Clin Dermatol 15:199–206

    PubMed  Google Scholar 

  116. De Villiers E-M (1998) Human papillomavirus infections in skin cancers. Biomed Pharmacother 52:26–33

    PubMed  Google Scholar 

  117. Dillner J (1999) The serological response to papillomaviruses. Semin Cancer Biol 9:423–430

    PubMed  CAS  Google Scholar 

  118. Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG. (1999) A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 80:2437–2443

    PubMed  CAS  Google Scholar 

  119. Hildesheim A, Schiffman MH, Gravitt PE et al. (1994) Persistence of type specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:235–240

    PubMed  CAS  Google Scholar 

  120. International Agency for Research on Cancer (IARC) (1995) Human papillomaviruses. IARC, Monogr Eval Carcinog Risks Hum (Lyon, France)

    Google Scholar 

  121. Stubenrauch F, Laimins LA (1999) Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 9:379–386

    PubMed  CAS  Google Scholar 

  122. Walboomers JM, Jacobs MV, Manos MM et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19

    PubMed  CAS  Google Scholar 

  123. Zur Hausen H (1996) Papillomavirus infections — a major cause of human cancers. Biochim Biophys Acta 1288:F55-78

    Google Scholar 

  124. Zur Hausen H (1999) Viruses in human cancers. Eur J Cancer 35:1174–1181

    PubMed  Google Scholar 

  125. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R (1986) Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 315:230–234

    PubMed  CAS  Google Scholar 

  126. Bedi A, Miller CB, Hanson JL et al. (1995) Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 13:1103–1119

    PubMed  CAS  Google Scholar 

  127. Berger JR, Concha M (1995) Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirol 1:5–18

    PubMed  CAS  Google Scholar 

  128. Bofill-Mas S, Pina S, Girones R (2000) Documenting the epidemiologic patterns of polyomaviruses in human populatio ns by studying their presence in urban sewage. Appl Environ Microbiol 66:238–245

    PubMed  CAS  Google Scholar 

  129. Childs R, Sanchez C, Engler HW at al. (1998) High incidence of adenoand polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 22:889–893

    PubMed  CAS  Google Scholar 

  130. Dörries K (1996) Virus-host interactions and the diagnosis of human polyomavirus associated disease. Intervirology 39:165–175

    PubMed  Google Scholar 

  131. Dörries K (1998) Molecular biology and pathogenesis of humanpolyomavirus infections. Dev Biol Stand Basel 94:67–75

    Google Scholar 

  132. Eggers C, Stellbrink HJ, Buhk T, Dörries K (1999) Quantification of JC virus DNA in the cerebrospinal fluid of patients with human immunodeficiency virus-associated progressive multifocal leukoencephalopathy —a longitudinal study. J Infect Dis 180:1690–1694

    PubMed  CAS  Google Scholar 

  133. Gardner SD, Knowles WA (1994) Human polyomaviruses. In: Zuckerman AJ, Banatvala JE and Pattison JR (eds) Principles and practice of clinical virology. Wiley, Chichester, pp 635–651

    Google Scholar 

  134. Happe S, Besselmann M, Matheja P et al. (1999) Cidofovir (vistide) in therapy of progressive multifocal leukoencephalopathy in AIDS. Review of the literature and report of 2 cases. Nervenarzt 70:935–943

    PubMed  CAS  Google Scholar 

  135. Raj GV, Khalili K (1995) Transcriptional Regulation: Lessons from the human neurotropic polyomavirus, JCV. Virology 213:283–291

    PubMed  CAS  Google Scholar 

  136. Shah KV (2000) Human polyomavirus BKVand renal disease. Nephrol Dial Transplant 15:754–755

    PubMed  CAS  Google Scholar 

  137. Vallbracht A, Löhler J, Gossmann J et al. (1993) Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol 143:29–39

    PubMed  CAS  Google Scholar 

  138. Vianelli N, Renga M, Azzi A et al. (2000) Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation. Bone Marrow Transplant 25:319–20

    PubMed  CAS  Google Scholar 

  139. von Giesen HJ, Neuen-Jacob E, Dörries K et al. (1997) Diagnostic criteria and clinical procedures in HIV-1 associated progressive multifocal leukoencephalopathy. J Neurol Sci 147:63–72

    Google Scholar 

  140. Weber T, Major EO (1997) Progressive multifocal leukoencephalopathy: Molecular biology, pathogenesis and clinical impact Intervirology 40:98–111

    CAS  Google Scholar 

  141. Weber T, Trebst C, Frye S et al. (1997) Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 176:250–4

    PubMed  CAS  Google Scholar 

  142. Zu Rhein GM (1969) Association of papova-virions with a human demyelinating disease (progressive multifocal leukoencephalopathy). Prog Med Virol 11:185–247

    PubMed  Google Scholar 

  143. Anderson MJ, Jones SE, Fisher-Hoch SP et al. (1983) The human par-vovirus, the cause of erythema infectiosum (fifth disease)? Lancet I:1378

    Google Scholar 

  144. Brown KE, Anderson SM, Young NS (1993) Erythocyte P antigen: cellular receptor for B19 parvovirus. Science 262:114–119

    PubMed  CAS  Google Scholar 

  145. Brown KE, Hibbs JR Gallinella G et al. (1994) Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 330:1192–1196

    PubMed  CAS  Google Scholar 

  146. Cohen BJ, Beard S, Knowles WA et al. (1997) Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion. Transfusion 37:947–952

    PubMed  CAS  Google Scholar 

  147. Cossart Y-E, Cant B, Field AM, Widdows D (1975) Parvovirus like particles in human sera. Lancet I: 72–73

    Google Scholar 

  148. Hemauer A, Beckenlehner K, Wolf H, Lang B, Modrow S (1999) Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient. J Clin Virol

    Google Scholar 

  149. Hemauer A, Gigler A, Searle K et al. (1999) Prevalence of NS1-specific antibodies in patients infected with parvovirus B19 and in pregnant women. J Med Virol

    Google Scholar 

  150. Jordan J, Tiangco B, Kiss J, Koch W (1998) Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcome of transfusion recicpients. Vox Sang 75:97–102

    PubMed  CAS  Google Scholar 

  151. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS (1987) Chronic bone marrow failure due to persistent B19 parvovirus infections. N Engl J Med 317:287–289

    PubMed  CAS  Google Scholar 

  152. Kurtzman GJ, Cohen BJ, Meyers P, Amunullah A, Young NS (1988) Persistent B19 parvovirus infection as a cause of severe chronic amemia in children with acute lymphocytic leukemia. Lancet II: 1159–1162

    Google Scholar 

  153. Marchand S, Tchernia G, Hiesse C et al. (1999) Human parvovirus B19 infection in organ transplant recipients. Clin Transplant 13:17–24

    PubMed  CAS  Google Scholar 

  154. Moore TL, Bandlamudi R, Alam SM, Nesher G (1999) Parvovirus B19 infection mimicking systemic lupus erythematodes in a pediatric population. Semin Arthritis Rheum 28:314–318

    PubMed  CAS  Google Scholar 

  155. Moudgil A, Shidban H, Nast CC et al. (1997) Parvovirus B19 infectionrelated complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation 64:1847–1850

    PubMed  CAS  Google Scholar 

  156. Nagai K, Morohoshi T, Kudoh T, Yoto Y, Suzuki N, Matsunaga Y (1992) Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection. Brit J Hematol 80:131–132

    CAS  Google Scholar 

  157. Naides SJ, Scharosch LL, Foto F, Howard, EJ (1990) Rheumatologic manifestation of human parvovirus B19 infection in adults. Arthritis and Rheumatism 33:1297–1308

    PubMed  CAS  Google Scholar 

  158. Poblotzkiv A, Gigler A, Lang B, Wolf H, Modrow S (1995) Antibodies to parvovirus NS1 protein in infected individuals. J Gen Virol 76:519–527

    Google Scholar 

  159. Poblotzkiv A, Gerdes C, Reischl U, Wolf H, Modrow S (1996) Lymphoproliferative responses after infection with human parvovirus B19. J Virol 70:7327–7330

    Google Scholar 

  160. Prowse C, Ludlam CA, Yap PL (1997) Human parvovirus B19 and blood products. Vox Sang 72:1–10

    PubMed  CAS  Google Scholar 

  161. Public Health Working Party on Fifth Disease (1990) BMJ 300:116

    Google Scholar 

  162. Reid DM, Reid TM, Brown T, Rennie JA, Eastmond M (1985) Human parvovirus associated arthritis: a clinical and laboratory description. Lancet 1:422–425

    PubMed  CAS  Google Scholar 

  163. Santagostino E, Manucci PM, Gringeri A et al. (1997) Transmission of coagulation factor concentrates exposed to 100 degrees C after lyophilization. Transfusion 37:517–522

    PubMed  CAS  Google Scholar 

  164. Saunders PW, Reid MM, Cohen BJ (1986) Human parvoviurs induced cytopenias: a report of five cases. Brit J Hematol 63:407–410

    CAS  Google Scholar 

  165. Schleuning M, Jäger G, Holler E et al. (1999) Human parvovirus B19-associated disease in bone marrow transplantation. Infection 27:114–117

    PubMed  CAS  Google Scholar 

  166. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell, CR (1986) Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 58:921–936

    PubMed  CAS  Google Scholar 

  167. Yoto Y, Kudoh T, Haseyama K et al.(1995) Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol 91:1017–1018

    PubMed  CAS  Google Scholar 

  168. Young N (1988) Hematological and hematopeitic consequences of parvovirus B19 infection. Semin Hematol 25:159–172

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abt. für Virologie, Universität Heidelberg, Hygiene-Institut, Im Neuenheimer Feld 324, 69120, Heidelberg, Deutschland

    Prof. Dr. J. J. Bugert & Prof. Dr. G. Darai

  2. Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Paul-Ehrlich-Str. 40, 60596, Frankfurt/Main, Deutschland

    Prof. Dr. J. Cinatl Jr. & Prof. Dr. H. W. Doerr

  3. Abt. Tumorvirus-Charakterisierung, Referenzzentrum für humanpathogene Papillonmaviren, Im Neuenheimer Feld 242, 69120, Heidelberg, Deutschland

    Priv.-Doz. Dr. E.-M. Villiers

  4. Institut für Virologie der Universität Würzburg, Versbacherstr. 7, 79078, Würzburg, Deutschland

    Prof. Dr. Dörries Kristina

  5. Abt. Virologie, Haus 47, Universitätsklinikum des Saarlandes, Kirrberger Str., 66424, Homburg, Deutschland

    B.C. Gärtner Dr. & Prof. Dr. Mueller-Lantzsch N.

  6. Institut für Medizinische Virologie, Justus-Liebig-UniversitätGiessen, Frankfurter Str. 107, 35392, Giessen, Deutschland

    Prof. Dr. W. Gerlich

  7. Medizinische Klinik I, Westpfalz-Klinikum, Hellmut-Hartert-Str. 1, 67653, Kaiserslautern, Deutschland

    Prof. Dr. H. Link

  8. Institut für klinische Mikrobiologie und Hygiene, Universität Regensburg, Franz-Josef-Stauss-Allee 11, 93053, Regensburg, Deutschland

    Prof. Dr. Modrow Susanne

  9. Institut für Med. Virologie, Zentrum der Hygiene im Klinikum der Joh.-Wolfg.-Goethe-Universität, Paul-Ehrlich-Str. 40, 60596, Frankfurt am Main, Deutschland

    W. Preiser Dr.

  10. Institut für Virologie und Seuchenhygiene, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

    P. Pring-Åkerblom Dr.

  11. Institut für Infektiologie, Mikrobiologie und Hygiene, Charité, Campus Buch, Wiltbergstr. 50, 13122, Berlin, Deutschland

    Doz. Dr. H. Scholz

  12. Medizinische Klinik III, Kreiskrankenhaus Hofheim, Lindenstr. 10, 65719, Hofheim/Taunus, Deutschland

    Prof. Dr. F. Vogel

  13. Institut für antivirale Chemotherapie, Universität Jena, Nordhäuser Str. 78, 99089, Erfurt, Deutschland

    Prof. Dr. P. Wutzier

Authors
  1. Prof. Dr. J. J. Bugert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. J. Cinatl Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. G. Darai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Priv.-Doz. Dr. E.-M. Villiers
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Prof. Dr. H. W. Doerr
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Prof. Dr. Dörries Kristina
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B.C. Gärtner Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Prof. Dr. W. Gerlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Prof. Dr. H. Link
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Prof. Dr. Modrow Susanne
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Prof. Dr. Mueller-Lantzsch N.
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. W. Preiser Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. P. Pring-Åkerblom Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Doz. Dr. H. Scholz
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Prof. Dr. F. Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Prof. Dr. P. Wutzier
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dr. von Haunersches Kinderspital der Ludwig-Maximilians-Universität, Lindwurmstr. 4, 80337, München, Deutschland

    D. Adam

  2. Institut für Medizinische Virologie des Klinikums, Johann-Wolfgang-Goethe-Universität Frankfurt/M., Paul-Ehrlich-Str. 40, 60596, Frankfurt, Deutschland

    H. W. Doerr

  3. Westpfalz-Klinikum, Medizinische Klinik I, Hellmut Hartert Str. 1, 67653, Kaiserslautern, Deutschland

    H. Link

  4. Zentralklinik Emil von Behring Pneumologische Abteilung I, Zum Heckeshorn 33, 14109, Berlin, Deutschland

    H. Lode

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bugert, J.J. et al. (2004). Virale Erkrankungen durch DNA-Viren. In: Adam, D., Doerr, H.W., Link, H., Lode, H. (eds) Die Infektiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18577-9_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18577-9_24

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00075-4

  • Online ISBN: 978-3-642-18577-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation